Personalized Drug Therapy in Cystic Fibrosis: From Fiction to Reality

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|9|1007-1017

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.9, 2015-01, pp. : 1007-1017

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis: Progress to Date

By Becq Frédéric  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 241-259

Adis International

Access to resources Recommend Favorite

Drug Disposition in Cystic Fibrosis

By Rey E.   Tréluyer J-M.   Pons G.  

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite

Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 2, 2017-08 ,pp. : 117-129

Bentham Science Publishers

Access to resources Recommend Favorite

Gene therapy for cystic fibrosis

By Boyd A.C.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 1-15

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for cystic fibrosis

By Kitson C.   Alton E.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1523-1535

Informa Healthcare

Access to resources Recommend Favorite